The global pet diabetes care devices market is witnessing unprecedented growth, fueled by an increasing demand for innovative healthcare solutions for pets. Valued at USD 2.3 billion in 2023, the market is projected to nearly double to USD 4.3 billion by 2033, expanding at a robust CAGR of 6.2% over the forecast period.
Veterinary clinics play a pivotal role in this market expansion, serving as essential facilitators in the adoption and effective use of pet diabetes care devices. These advanced tools, such as insulin pens, glucose monitoring systems, and glucose meters, are designed with pet-specific functionalities to aid in detecting, monitoring, and managing diabetes in pets. Their use not only helps prevent complications but also ensures a better quality of life for pets.
Veterinary Clinics Driving Adoption:
Veterinary clinics have emerged as trusted advisors for pet owners, guiding them in understanding their pets’ health conditions and the benefits of diabetes care devices. By recommending and educating pet owners on these tools, clinics enable seamless integration of advanced healthcare solutions into routine pet care. Furthermore, they emphasize the importance of regular blood glucose monitoring and nutritious diets, equipping pet owners with comprehensive knowledge to manage their pets’ diabetes effectively.
Growing Awareness Among Pet Owners:
The rise in diabetes diagnoses among pets has sparked a wave of awareness among pet owners, who are increasingly seeking advanced solutions to manage their pets’ health. By utilizing pet diabetes care devices, owners can monitor their pets’ glucose levels, administer insulin with precision, and ensure proactive care—leading to healthier and happier pets.
Market Outlook:
The market’s growth trajectory underscores the critical role of veterinary clinics in expanding access to effective pet diabetes management tools. By providing in-depth training on device usage and offering continuous support for home monitoring, veterinary professionals empower pet owners to actively participate in their pets’ healthcare journey.
As the pet diabetes care devices market continues to expand, these advanced solutions are transforming the landscape of pet healthcare, fostering improved outcomes and enhanced well-being for pets worldwide.
Key Takeaways:
- The pet diabetes care devices market is registering a CAGR of 6.2% with a valuation of USD 4.3 billion by 2033.
- In the historical period, the market captured a CAGR of 5.7%, with a valuation of USD 1.7 billion in 2018.
- The United States is a prominent leader in the global market, registering a share of 27% during the forecast period.
- China is one of the significant countries in the Asia Pacific that securing a CAGR of 8.20% by 2033.
- During the forecast period, India is registering a CAGR of 7.50% in the global market.
Increased Market Insight Demand: Get Thorough Analysis and Trends in Our Complete Report!
How Key Players are Focus on Adding Values in the Global Market?
Key players are focusing on innovating pet diabetes care devices by adding advanced features resulting in accuracy, convenience, and ease to use. The key players are deploying small sensors in these devices to monitor pets’ health conditions, such as blood glucose levels. These devices work on a real-time basis as pet owners track the condition of their pets and provide them with healthy nutrition with a proper dietary plan.
The key players developing specially design insulin syringes to provide more accurate information than other devices. These devices provide quick results, increasing the adoption of pet healthcare to treat pets’ poor health conditions. Conversely, guiding pet owners, growing awareness, and innovating easy-to-access pet care devices improve pet health.
Recent Developments in the Global Pet Diabetes Care Devices Market are:
- In September 2021, Zoetis Inc launched its new product VETSCAN IMAGYST. This device offers to monitor pets’ diabetes and health conditions.
- In July 2021, Merck Animal Health launched Vetsulin to manage pets’ diabetes.
- In 2020, IDEXX Laboratories announced its new product device IDEXX SDMA Test to identify kidney disease in cats and dogs and also the complication of diabetes.
- In 2019, Vetoquinol announced its acquisition with Epitopix to provide vaccination for diabetes-diagnosed pets.
Other Essential Players in the Global Market are:
- Abbot Laboratories, Inc
- Virbac
- Medtronic plc
- Johnson & Johnson Services, Inc
- Roche Diagnostics
- Bio-Rad Laboratories, Inc
- Novo Nordisk A/S
- Zoetis Inc
- Terumo Corporation
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories
- Johnson & Johnson Services, Inc
- Terumo Corporation
- Eli Lilly and Company
- Vetoquinol S.A.
Pet Diabetes Care Devices Market by Category:
By Animal Type:
- Cats
- Dogs
- Horses
By Device:
- Insulin Delivery Devices
- Insulin Delivery Pen
- Insulin Syringes
- Glucose Monitoring Devices
By End User:
- Veterinary Clinics
- Home Care Settings
- Veterinary Hospitals
Region:
- North America
- Europe
- Latin America
- Asia Pacific
- The Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
